A UK Parliamentary debate on 18 May saw crossparty calls to conduct an urgent review of the evidence for psilocybin’s current status as a Schedule 1...
The Royal College of Psychiatrists, Heroic Hearts and other leading mental health charities have written letters to the Veterans Minister and the Minister of State for...
The use of psychedelics in research has a long and storied history, dating back to the mid-20th century.
An increasing amount of research is showing psychedelics as promising treatments for a variety of mental health conditions, however, a group of experts have emphasised the...
Regulatory approvals for psychedelic medicines are becoming a reality, and the focus in policy and advocacy work is shifting from “if” to “when” and – most...
The Dutch Parliament has established an independent State Commission to research the legal status of MDMA and provide advice on its medical use.
When psychedelic therapies begin to gain regulatory approval, they will need to be incorporated into the medical billing and coding system in a way that ensures...
In what has been described as a “historic trial”, ICEERS has suggested that the verdict of an ayahuasca trial in Mexico opens the door for the...
In response to a letter from a group of cross-party MEPs calling for the EU to act fast on psychedelics, the European Medicines Agency will be...
Over 100 academics, psychologists, anthropologists and activists have signed a manifesto launched by the Chacruna Institute for Psychedelic Plant Medicines calling for an end to police...
